Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Enrolling by invitation × Dexamethasone × Clear all

Phase

Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 107 Terminated 35 Active not recruiting 17 Recruiting 14 Withdrawn 9 Unknown 6 Not yet recruiting 4 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

toripalimab 1 ibrutinib 1 fludarabine 1 Spinal Puncture 1 Positron-Emission Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 JNJ-64619178 1 JNJ-64264681 1 Dexamethasone 1 Deoxycholic Acid 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07014462 2025-10-06

DLIT-AML

University of Vermont

Phase 1 Enrolling by invitation

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡